Clinical Trial

Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock Patients

Study acronym: PulseSE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to investigate the safety and efficacy of the Synchronized Cardiac Support treatment wit the icor kit and the Xenios console with modified sensor box ECG and Software Version 3.2.4
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-10-22; most recent amendment 2025-03-13.
Trial Details
NCT Number NCT05106491
Lead Sponsor Xenios AG
Conditions Cardiogenic Shock, Extracorporeal Membrane Oxygenation, ECLS, VA ECMO
Enrollment 21 participants
Start Date 2025-09
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-03-14